{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:02:38Z","timestamp":1788357758230,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The objective of this study was to evaluate how the number of demyelinating findings (DF) on nerve conductions affects sensitivity and specificity of electrodiagnostic criteria for chronic inflammatory demyelinating polyneuropathy (CIDP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Electrodiagnostic findings of 26 consecutive patients with CIDP were compared with amyotrophic lateral sclerosis (ALS) and diabetic polyneuropathy controls. Patients with CIDP were divided into typical and atypical CIDP, as defined elsewhere.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Depending on the minimal required number (MRN) of DF on nerve conductions, sensitivities decreased from an arbitrary 100% to 58% and 54%, for an MRN of 1, 2, and 3, respectively, as specificities increased, from 48% to 81% and 95%, respectively. The number of DF per patient was higher in typical CIDP than in atypical CIDP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The considerable gap between specificity and sensitivity is the reason for controversy regarding the MRN for the diagnosis of CIDP. Requiring 2 or more DFs to identify CIDP increases specificity from 48% to 81% but lowers sensitivity from 100% to 58%. For patients with other potential causes of neuropathy, the requirement of 2 or more DFs could further increase specificity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cnd.0b013e31819a71e1","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T07:45:29Z","timestamp":1243842329000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Demyelinating Findings in Typical and Atypical Chronic Inflammatory Demyelinating Polyneuropathy: Sensitivity and Specificity"],"prefix":"10.1097","volume":"10","author":[{"given":"Eduardo A","family":"De Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell L","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard W","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Latov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Brannagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240808","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy.","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"key":"R2-1-20240808","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jocn.2006.11.001","article-title":"Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.","volume":"14","author":"Rentzos","year":"2007","journal-title":"J Clin Neurosci"},{"key":"R3-1-20240808","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy.","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"R4-1-20240808","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force.","volume":"41","year":"1991","journal-title":"Neurology"},{"key":"R5-1-20240808","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies.","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle Nerve"},{"key":"R6-1-20240808","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mus.1214","article-title":"Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy.","volume":"25","author":"Nicolas","year":"2002","journal-title":"Muscle Nerve"},{"key":"R7-1-20240808","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/archneur.60.12.1755","article-title":"Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.","volume":"60","author":"Magda","year":"2003","journal-title":"Arch Neurol"},{"key":"R8-1-20240808","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1085-9489.2005.10302.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.","volume":"10","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"R9-1-20240808","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1468-1331.2006.01259.x","article-title":"Treatment response and electrophysiological criteria in chronic inflammatory demyelinating polyneuropathy.","volume":"13","author":"Cocito","year":"2006","journal-title":"Eur J Neurol"},{"key":"R10-1-20240808","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria.","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch Neurol"},{"key":"R11-1-20240808","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1085-9489.2003.03031.x","article-title":"Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.","volume":"8","author":"Berger","year":"2003","journal-title":"J Peripher Nerv Syst"},{"key":"R12-1-20240808","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"key":"R13-1-20240808","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000103645","article-title":"A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.","volume":"58","author":"Misra","year":"2007","journal-title":"Eur Neurol"},{"key":"R14-1-20240808","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy.","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"key":"R15-1-20240808","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block.","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"key":"R16-1-20240808","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome.","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle Nerve"},{"key":"R17-1-20240808","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/01.WNL.0000034172.47882.20","article-title":"Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy.","volume":"59","author":"Thaisetthawatkul","year":"2002","journal-title":"Neurology"},{"key":"R18-1-20240808","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/mus.880141007","article-title":"Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy.","volume":"14","author":"Bromberg","year":"1991","journal-title":"Muscle Nerve"},{"key":"R19-1-20240808","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.57.12.1745","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria.","volume":"57","author":"Haq","year":"2000","journal-title":"Arch Neurol"},{"key":"R20-1-20240808","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.","volume":"29","author":"Van den Bergh","year":"2004","journal-title":"Muscle Nerve"},{"key":"R21-1-20240808","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/mus.20475","article-title":"A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP.","volume":"33","author":"Echaniz-Laguna","year":"2006","journal-title":"Muscle Nerve"},{"key":"R22-1-20240808","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/mus.21010","article-title":"Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis.","volume":"38","author":"Rajabally","year":"2008","journal-title":"Muscle Nerve"},{"key":"R23-1-20240808","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/(SICI)1097-4598(199809)21:9<1228::AID-MUS20>3.0.CO;2-M","article-title":"Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy.","volume":"21","author":"Wilson","year":"1998","journal-title":"Muscle Nerve"},{"key":"R24-1-20240808","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.59.5.758","article-title":"Demyelinating neuropathy in diabetes mellitus.","volume":"59","author":"Sharma","year":"2002","journal-title":"Arch Neurol"},{"key":"R25-1-20240808","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.10320","article-title":"Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment.","volume":"27","author":"Dyck","year":"2003","journal-title":"Muscle Nerve"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00131402-200906000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T23:21:12Z","timestamp":1723159272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00131402-200906000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e31819a71e1","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}